Indaptus Therapeutics (INDP) Operating Leases (2020 - 2025)
Indaptus Therapeutics (INDP) posted quarterly Operating Leases of $8686.0 for Q3 2025, up 116.77% year-over-year from $4007.0 in Q3 2024, and down 74.73% quarter-over-quarter from $34373.0 in Q2 2025.
Indaptus Therapeutics (INDP) Operating Leases (2020 - 2025) Analysis & Trends
Indaptus Therapeutics' Operating Leases history runs 6 years deep, the most recent figure standing at $8686.0 for Q3 2025.
- In Q3 2025, Operating Leases rose 116.77% year-over-year to $8686.0; the TTM figure through Sep 2025 stood at $8686.0 (up 116.77% YoY), while the FY2024 annual figure was $84164.0, up 14.75% from the prior year.
- Operating Leases for Q3 2025 stood at $8686.0, down from $34373.0 in the prior quarter.
- The five-year high for Operating Leases was $236506.0 in Q1 2023, with the low at $4007.0 in Q3 2024.
- The 5-year median for Operating Leases is $84164.0 (2024), against an average of $100482.1.
- The sharpest annual moves came in 2023 and 2024: Operating Leases soared 368.18% in 2023, then sank 97.96% in 2024.
- Indaptus Therapeutics' Operating Leases stood at $72862.0 in 2021, then grew by 10.47% to $80494.0 in 2022, then decreased by 8.88% to $73348.0 in 2023, then climbed by 14.75% to $84164.0 in 2024, then sank by 89.68% to $8686.0 in 2025.
- Business Quant data shows INDP's Operating Leases at $8686.0 in Q3 2025, $34373.0 in Q2 2025, and $59512.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,686.00 |
| Jun 30, 2025 | 34,373.00 |
| Mar 31, 2025 | 59,512.00 |
| Dec 31, 2024 | 84,164.00 |
| Sep 30, 2024 | 4,007.00 |
| Jun 30, 2024 | 130,802.00 |
| Mar 31, 2024 | 153,128.00 |
| Dec 31, 2023 | 73,348.00 |
| Sep 30, 2023 | 196,241.00 |
| Jun 30, 2023 | 116,170.00 |
| Mar 31, 2023 | 236,506.00 |
| Dec 31, 2022 | 80,494.00 |
| Sep 30, 2022 | 103,574.00 |
| Jun 30, 2022 | 125,812.00 |
| Mar 31, 2022 | 50,516.00 |
| Dec 31, 2021 | 72,862.00 |
| Mar 31, 2021 | 178,000.00 |
| Dec 31, 2020 | 338,000.00 |